chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Headache, Heart rate, Heart rate increased, Mental status changes
Clinical narrative: fast heartbeat; increased BP; weak; dizziness; nausea; headache; confused; a little soreness in her arm; felt like she could pass out; didn't know who she was, she just kept walking and walking; funny feelings; This is a spontaneous report from a contactable consumer (patient). An 84-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EL0142, expiry date not reported), via an unspecified route of administration on the right upper arm on 21Jan2021 17:00 at single dose for covid-19 immunization.  Medical history included oral cancer from an unknown date and unknown if ongoing.  There were no concomitant medications. The patient previously received flu vaccine for immunization and reported that it made her sick for 10 days 4 or 5 years ago. The patient previously took Tylenol (takes 1 instead of 2, Everything she takes half the recommended dose). The patient experienced fast heartbeat, increased BP, weakness, dizziness, nausea and headache on an unspecified date in Jan2021. It was further reported that she had a fast heart beat, her blood pressure went real high, she was dizzy and weak. This was while she was there and being watched for the 15 minutes by a nurse. She is 84 years old and doesn't take any medication; she did have oral cancer but with no chemo as it had not spread and this was 2 years ago. It was explained that the patient didn't feel good about it but she drove home. When she got home she was confused and felt like she could pass out. She walked through the house didn't know who she was, she just kept walking and walking. It was a strange feeling that lasted 15-20 minutes. She called her son late in the afternoon and told him to check on her to make sure she made it through the night. She still had funny feelings over the next few days but at this point she only has the dizziness that happens occasionally. She notes also that her blood pressure was checked at home by her and was higher than normal the first few days after but is now normal. Over the next day she had a headache and a little nausea, but it was not severe. She also mentions having a little soreness in her arm but not bad. She did read about the side effects and states she had the elevated heart rate, increase in blood pressure and dizziness right after getting it. The patient wonders could she ask for smaller dose, she only weighs about 110lb. When she spoke with her doctor she was told that the COVID virus is worse than what she experienced after the vaccine. She has not been to the doctor since getting the vaccine, she just talked to them. The patient underwent lab tests and procedures which included blood pressure measurement: high and heart rate: fast on Jan2021. The patient was recovering from dizziness, the outcome of nausea was unknown and the patient recovered from the rest of the events on an unspecified date in Jan2021.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pain in extremity, Presyncope
Clinical narrative: fast heartbeat; increased BP; weak; dizziness; nausea; headache; confused; a little soreness in her arm; felt like she could pass out; didn't know who she was, she just kept walking and walking; funny feelings; This is a spontaneous report from a contactable consumer (patient). An 84-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EL0142, expiry date not reported), via an unspecified route of administration on the right upper arm on 21Jan2021 17:00 at single dose for covid-19 immunization.  Medical history included oral cancer from an unknown date and unknown if ongoing.  There were no concomitant medications. The patient previously received flu vaccine for immunization and reported that it made her sick for 10 days 4 or 5 years ago. The patient previously took Tylenol (takes 1 instead of 2, Everything she takes half the recommended dose). The patient experienced fast heartbeat, increased BP, weakness, dizziness, nausea and headache on an unspecified date in Jan2021. It was further reported that she had a fast heart beat, her blood pressure went real high, she was dizzy and weak. This was while she was there and being watched for the 15 minutes by a nurse. She is 84 years old and doesn't take any medication; she did have oral cancer but with no chemo as it had not spread and this was 2 years ago. It was explained that the patient didn't feel good about it but she drove home. When she got home she was confused and felt like she could pass out. She walked through the house didn't know who she was, she just kept walking and walking. It was a strange feeling that lasted 15-20 minutes. She called her son late in the afternoon and told him to check on her to make sure she made it through the night. She still had funny feelings over the next few days but at this point she only has the dizziness that happens occasionally. She notes also that her blood pressure was checked at home by her and was higher than normal the first few days after but is now normal. Over the next day she had a headache and a little nausea, but it was not severe. She also mentions having a little soreness in her arm but not bad. She did read about the side effects and states she had the elevated heart rate, increase in blood pressure and dizziness right after getting it. The patient wonders could she ask for smaller dose, she only weighs about 110lb. When she spoke with her doctor she was told that the COVID virus is worse than what she experienced after the vaccine. She has not been to the doctor since getting the vaccine, she just talked to them. The patient underwent lab tests and procedures which included blood pressure measurement: high and heart rate: fast on Jan2021. The patient was recovering from dizziness, the outcome of nausea was unknown and the patient recovered from the rest of the events on an unspecified date in Jan2021.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Sore arm; This is a spontaneous report received from a contactable consumer (patient). A female patient of an unspecified age (reported as 70, unit not provided, pending clarification) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date unknown), via an unspecified route of administration, on 24Jan2021, at single dose, for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient experienced sore arm from the injection in Jan2021. The patient was concerned as she stated that her shot did not even take a sec, it was quickly administered and she saw in the TV that it was given slowly. The patient wanted to know if it takes 2 weeks for the antibodies to be made after the first dose, wanted to know about new strain and if its covered by the vaccine, if she should continue to wear mask and social distancing after the vaccine, and how many ml/mg is the medication. The outcome of the event was unknown.  Information about lot/batch number has been requested.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: swelling of lymph nodes on same arm of injection site; This is a spontaneous report from a contactable consumer (patient). A 41-year-old female patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL0140, expiry date: not reported), via an unspecified route of administration, on 20Jan2021 14:30, at a single dose on the left arm for COVID-19 immunization. The vaccine was administered at a hospital. Medical history and concomitant medications were none. Family Medical History Relevant to the adverse event: Patient's mother has bad allergies and knows she is contraindicated to this vaccine, but patient has never experienced any allergic reaction to anything. The patient previously received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL0140, expiry date: not reported), via an unspecified route of administration, on 30Dec2020 1:30 pm, at a single dose on the left arm for COVID-19 immunization (age at vaccination: 41-year-old). The patient was administered her first dose the vaccine on 30Dec2020. She was administered her second dose of Pfizer COVID-19 Vaccine 20Jan2021, completing treatment. On 23Jan2021 08:00, three days after receiving the second dose of the vaccine she experienced swelling of lymph nodes on same arm of injection site. She reported onset of swollen lymph nodes in left arm 23Jan2021 which is ongoing. The swollen lymph nodes are present in the same arm that she was administered both first and second doses. She looked on the CDC website and did not know that this was a reported a side effect of the vaccine. She assumes it will go away. She called to clarify if she should tell her healthcare provider about this or if there are any recommendations regarding this event. She has taken some Motrin to help with the swelling. The event did not require a visit to the emergency room of physician's office.  Therapeutic measures taken as a result of the adverse event included Motrin. Outcome of the event was not recovered. The patient assessed the event as non-serious. She does believe the event was potentially caused by the vaccine.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Feeling hot, Insomnia, Pain, Somnolence
Clinical narrative: struggled to stay awake; achy; hot; couldn't get back to sleep; very tired; This is a spontaneous report from a contactable consumer.  A 44-year-old female patient received the second dose of   BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, lot number: EL3249) in the hospital, via an unspecified route of administration on 20Jan2021 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient was not diagnosed with COVID-19 prior to vaccination. It was unknown if the patient received other vaccines within 4 weeks prior to the COVID vaccine and it was also unknown if the patient received any other medications within 2 weeks of the vaccination. The patient received the first dose of BNT162B2 (lot number: EJ1685) in the hospital on 30Dec2020 for COVID-19 immunization. It was reported that on 21Jan2021, the patient struggled to stay awake. She took Tylenol and woke achy and hot at midnight and couldn't get back to sleep.  She woke again at 2:30 AM and took Motrin and got back to sleep about 3:30 AM still hot and achy.  By 5:30 AM, she said she was less hot and achy, but very tired. Treatment was recevied for events struggled to stay awake, achy, hot and couldn't get back to sleep. It was unknown if treatment was received for the event very tired. The outcome of the events was unknown. The events were reported as non-serious.  Since the vaccination, it is unknown if the patient had been tested for COVID-19.
Sex: M
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Headache; This is a spontaneous report from a contactable consumer. A 35-year-old male patient received  the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration in Jan2021 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient experienced headache about 30 hours after receiving second vaccine dose (Jan2021). No treatment was received for the event. The outcome of the event was recovered in Jan2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Soreness at the site of injection; This is a spontaneous report from a contactable consumer (patient).  A 50-year-old male patient received BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, lot number unknown) in the workplace clinic, via an unspecified route of administration on 22Jan2021 at 10:30 on the left arm at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced soreness at the site of injection during 12-24 hours post administration on 22Jan2021 at 22:00. The outcome of the event was recovered.  The patient did not receive treatment for the event. The event was reported as non-serious.   Information on the lot/batch number has been requested.
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Neuralgia
Clinical narrative: neuropathic pain; bilateral feet burning, burning in both calves and slight extent to both hands; This is a spontaneous report from a contactable healthcare professional (patient). A 57-year-old female patient [unknown age of vaccination] received bnt162b2 (BNT162B2 reported as PFIZER-BIONTECH COVID-19 VACCINE; unknown lot number and expiration date), via an unspecified route of administration on an unspecified date at a single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient reported that she was experiencing neuropathic pain, bilateral feet burning, burning in both calves and slight extent to both hands on an unspecified date. She inquired if there were other reports like this. The outcome of the events was unknown.  The following information on the batch/lot number has been requested.
Sex: F
Vaccine: COVID19
Symptoms: Headache, Heart rate, Heart rate increased, Vaccination site hypoaesthesia
Clinical narrative: really bad headaches; heart rate is a little higher than usual; numbness at the side of the shot; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age (reported as 45 [units unspecified]) received her first dose of bnt162b2 (BNT162B2 reported as PFIZER-BIONTECH COVID-19 VACCINE; unknown lot number and expiration date), via an unspecified route of administration on 16Jan2021 at a single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. She had her first dose of the vaccine on 16Jan2021 and had no side effects, just "numbness at the side of the shot". She mentioned however, since Sunday (24Jan2021), she's been having "really bad headaches" and has noticed that her "heart rate is a little higher than usual". The patient reported she had headaches more than 1 week after receiving the vaccine. She added that she didn't really have any symptoms, but she know like the main symptoms were within like the 3 day period. She has been experiencing the symptoms now and she doesn't know if it could be like a delayed reaction to the vaccine but she had the curiosity and wanted to report if and see if it is the delayed reaction or something else. The outcome of the events was unknown.  The following information on the batch/lot number has been requested.
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: swelling of her lymph nodes; This is a spontaneous report from a contactable consumer (patient). A 27-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date unknown), via an unspecified route of administration, on 08Jan2021, at single dose, for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced swelling of her lymph nodes on 22Jan2021, 2 weeks after getting the vaccine. The outcome of the event was unknown. The patient wanted to know if this was a normal side effect of the vaccine. The patient also wanted to know the risks of the Pfizer-Biontech covid-19 vaccine and what should she do about the side effects.  Information about the lot/batch number has been requested.
Sex: F
Vaccine: COVID19
Symptoms: Rash, Rash erythematous
Clinical narrative: a real bad rash that was not severe, just red, sore, and irritating; a real bad rash that was not severe, just red, sore, and irritating; This is a spontaneous report from a consumer (patient). A female patient of an unspecified age received first dose bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date not reported), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. The patient stated that after first dose,  3-4 days after she got a real bad rash that was not severe, just red, sore, and irritating. It started coming slowly. Rash was located on her neck. The patient was unsure if the rash was from the vaccine.  The patient thought, maybe she put too much chemical on her hair/head. Clinical outcome of the events was unknown.  Information about lot/batch number has been requested.
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea, Oropharyngeal pain, Pain, Pain in extremity, Pyrexia
Clinical narrative: sore arms; fever; body aches/pain; sore throat; diarrhea; This is a spontaneous report from a contactable consumer (patient) via a medical information team. A male patient of an unspecified age received first dose BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. It was reported that during the first dose of BNT162B2, the patient experienced sore arms, fever, body aches, pain, sore throat, and diarrhea. The patient has tested negative for COVID on unspecified date. The patient stated, "Can I use Benadryl after getting vaccinated?" The outcome of the events was unknown.  Information on the lot/batch number has been requested.
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test
Clinical narrative: sore arms; fever; body aches/pain; sore throat; diarrhea; This is a spontaneous report from a contactable consumer (patient) via a medical information team. A male patient of an unspecified age received first dose BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. It was reported that during the first dose of BNT162B2, the patient experienced sore arms, fever, body aches, pain, sore throat, and diarrhea. The patient has tested negative for COVID on unspecified date. The patient stated, "Can I use Benadryl after getting vaccinated?" The outcome of the events was unknown.  Information on the lot/batch number has been requested.
Sex: F
Vaccine: COVID19
Symptoms: Neck pain
Clinical narrative: I have some pain in my neck; This is a spontaneous report from a contactable consumer via the Medical Information Team. A female patient of an unspecified age received her first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. It was reported by the patient that she has some pain in her neck unrelated to the vaccine. She is due to receive her steroid shot. The outcome of the event was unknown.  Information on the lot/batch number has been requested.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Pain in extremity
Clinical narrative: Fatigue; Arm pain; Headaches; This is a spontaneous report from a contactable consumer (patient). A 41-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiry date: unknown), via an unspecified route of administration on the right arm, on 25Jan2021 16:45 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Patient was not pregnant at the time of vaccination. There was no other vaccine received within four weeks prior to vaccination. The patient experienced fatigue, arm pain, headaches Jan2021. Outcome of the events was unknown and no treatment was given. Events were considered non-serious. Patient was not diagnosed with COVID-19 prior to vaccination and had not been tested since the vaccination.  Information on the lot/batch number has been requested.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Pain in arm; This is a spontaneous report from a contactable other health care professional (patient). A 40-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number el9261 and expiration date not provided), via an unspecified route of administration (left arm) first dose on 25Jan2021 15:00 at single dose for Covid-19 immunization. The patient's medical history and concomitant medications were not reported.  The patient was not pregnant at time of vaccination. On 26Jan2021 04:00, the patient experienced pain in arm.  The patient did not received treatment for then event. The outcome of the event was recovering. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. No medication was taken within 2 weeks of vaccination.
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia oral
Clinical narrative: felt a very slight tingling on her lips; This is a spontaneous report from a non-contactable consumer (patient) via the Pfizer-sponsored program. A female patient of unspecified age received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date were not reported), via an unspecified route of administration, on an unspecified date in Jan2021 at a single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. The patient received the 1st dose of the bnt162b2 a few days prior to the date of this report in Jan2021. However, after 5 minutes, she felt a very slight tingling on her lips that lasted for about 10 minutes. HCP wants to know if she should still receive the 2nd dose. Outcome of the event was recovered on an unspecified date in Jan2021. The reporter assessed the event as non-serious.   No follow-up attempts are possible. Information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pain in extremity
Clinical narrative: Sore arm; Tiredness; This is a spontaneous report from a contactable consumer. An elderly female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number and expiration date were not reported) at a single dose, with route of administration and therapy date unspecified, for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient had previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number and expiration date were not reported) on an unspecified date for COVID-19 immunization. The patient was not pregnant at the time of vaccination. In Jan2021, the patient had sore arm and tiredness. The patient did not receive any treatment for the reported events. The outcome of the events, sore arm and tiredness, was recovered in Jan2021. The patient was not diagnosed with COVID-19 prior to vaccination, and had not been tested post-vaccination.  Information about lot/batch has been requested.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Fatigue, Headache, Loss of personal independence in daily activities
Clinical narrative: It's the longevity of the side effects at a level preventing work and daily activities that is the biggest problem; fatigue; headaches; fevers; chills; dizziness; generalized pain; This is a spontaneous report from a contactable nurse (patient). A 47-year-old female patient received the second dose of bnt162b2 (BNT162B2, lot number: EL324, expiry date: not reported), via unspecified route of administration on 22Jan2021 05:00 PM at a single dose on the left arm for COVID-19 immunization. The vaccine was administered at a hospital. The patient did not receive any other vaccine in four weeks prior vaccination. Medical history included epilepsy and asthma. Concomitant medications included lamotrigine (LAMICTAL), escitalopram oxalate (LEXAPRO), riboflavin (VITAMIN b2), magnesium (MAGNESIUM), ascorbic acid, betacarotene, cupric oxide, manganese sulfate, selenium, tocopheryl acetate, ubidecarenone, zinc oxide (COQ10). The patient previously received the first dose of bnt162b2 (BNT162B2, lot number: EL1284, expiry date: not reported), via unspecified route of administration on 02Jan2021 07:00 PM at a single dose on the left arm for COVID-19 immunization (age at vaccination: 47-year-old). Past drug history included known allergies to Parafon forte and Macrobid. The patient stated that it's the longevity of the side effects at a level preventing work and daily activities that is the biggest problem. She stated that she's 5 days post injection at the time of report (26Jan2021), and the fatigue, headaches, fevers/chills, dizziness and generalized pain are not going away (started on an unspecified date in Jan2021). Her doctor told me to report this to the manufacturer and get advice. No treatment was received. The patient did not have covid prior vaccination and was not tested for covid post vaccination.  Outcome of the events was recovering.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pyrexia
Clinical narrative: It's the longevity of the side effects at a level preventing work and daily activities that is the biggest problem; fatigue; headaches; fevers; chills; dizziness; generalized pain; This is a spontaneous report from a contactable nurse (patient). A 47-year-old female patient received the second dose of bnt162b2 (BNT162B2, lot number: EL324, expiry date: not reported), via unspecified route of administration on 22Jan2021 05:00 PM at a single dose on the left arm for COVID-19 immunization. The vaccine was administered at a hospital. The patient did not receive any other vaccine in four weeks prior vaccination. Medical history included epilepsy and asthma. Concomitant medications included lamotrigine (LAMICTAL), escitalopram oxalate (LEXAPRO), riboflavin (VITAMIN b2), magnesium (MAGNESIUM), ascorbic acid, betacarotene, cupric oxide, manganese sulfate, selenium, tocopheryl acetate, ubidecarenone, zinc oxide (COQ10). The patient previously received the first dose of bnt162b2 (BNT162B2, lot number: EL1284, expiry date: not reported), via unspecified route of administration on 02Jan2021 07:00 PM at a single dose on the left arm for COVID-19 immunization (age at vaccination: 47-year-old). Past drug history included known allergies to Parafon forte and Macrobid. The patient stated that it's the longevity of the side effects at a level preventing work and daily activities that is the biggest problem. She stated that she's 5 days post injection at the time of report (26Jan2021), and the fatigue, headaches, fevers/chills, dizziness and generalized pain are not going away (started on an unspecified date in Jan2021). Her doctor told me to report this to the manufacturer and get advice. No treatment was received. The patient did not have covid prior vaccination and was not tested for covid post vaccination.  Outcome of the events was recovering.
Age: 18.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pain
Clinical narrative: felt sharp pain behind right ear which lasted 2 hours; headache; This is a spontaneous report received from a contactable other healthcare professional (who is also the patient). An 18-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EN5318, expiry date: unknown), via an unspecified route of administration in the left arm, on 24Jan2021 13:00, at single dose, for COVID-19 immunization, at the workplace clinic. Medical history included depression. The patient was not pregnant at the time of vaccination. The patient has no known allergies. Concomitant medication included an unspecified birth control pill, melatonin and multivitamins. Historical vaccine included the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EJ1686, expiry date: unknown), via an unspecified route of administration in the left arm, on 03Jan2021 12:00, for COVID-19 immunization. The patient did not receive any other vaccine in four weeks. The patient did not have COVID-19 prior to vaccination and was not tested for COVID-19 post vaccination. On 24Jan2021 17:00, 4 hours after vaccination, the patient felt sharp pain behind right ear which lasted 2 hours. On 24Jan2021 15:00, a few hours after vaccination, the patient started having a headache which, as the patient reported, "hasn't gone away, even with a Tylenol, actually feels worse than when it started on Sunday". Treatment for the events included Tylenol, heat, and quiet and dark room. The outcome of the event "felt sharp pain behind right ear which lasted 2 hours" was recovered on 24Jan2021 at 19:00; and headache was not recovered.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Body temperature, Headache, Pyrexia, Vaccination site pain
Clinical narrative: fever chills/I recorded a temperature of 102 at 9pm; backache; Headache; swollen left underarm, same arm that she received the vaccine; same arm that she received the vaccine. Tender to touch; This is a spontaneous report from a contactable consumer.  A 25-year-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; lot number: EL9261), via an unspecified route of administration on 24Jan2021 17:30 at SINGLE DOSE in arm left for COVID-19 immunization. Medical history included eczema, migraine from an unknown date and unknown if ongoing.  Concomitant medication included biotin (BIOTIN), rizatriptan benzoate (RIZATRIPTAN BENZOATE). The patient received first dose of BNT162B2 on 03Jan2021 10:00 AM in left arm for covid19 immunization. On 25Jan2021, the patient experienced Headache when she woke up at 8am, by 12pm she also had a fever chills and backache. Symptoms did not improve even after 6 ibuprofen throughout the day. The patient recorded a temperature of 102 at 9pm. None of the above symptoms on 26Jan. However, had a significantly swollen left underarm, same arm that she received the vaccine. Tender to touch. If the swelling doesn't go down in 1-2 days the patient will visit an urgent care. The patient underwent lab tests and procedures which included body temperature: 102 on 25Jan2021. Therapeutic measures were taken as a result of headache (headache), fever chills (pyrexia), backache (back pain). The patient did not receive treatment for the events vaccination site swelling, and vaccination site pain.  The outcome of the events headache, fever chills was recovered on 26Jan2021, while unknown for the events vaccination site swelling, and vaccination site pain.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling
Clinical narrative: fever chills/I recorded a temperature of 102 at 9pm; backache; Headache; swollen left underarm, same arm that she received the vaccine; same arm that she received the vaccine. Tender to touch; This is a spontaneous report from a contactable consumer.  A 25-year-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; lot number: EL9261), via an unspecified route of administration on 24Jan2021 17:30 at SINGLE DOSE in arm left for COVID-19 immunization. Medical history included eczema, migraine from an unknown date and unknown if ongoing.  Concomitant medication included biotin (BIOTIN), rizatriptan benzoate (RIZATRIPTAN BENZOATE). The patient received first dose of BNT162B2 on 03Jan2021 10:00 AM in left arm for covid19 immunization. On 25Jan2021, the patient experienced Headache when she woke up at 8am, by 12pm she also had a fever chills and backache. Symptoms did not improve even after 6 ibuprofen throughout the day. The patient recorded a temperature of 102 at 9pm. None of the above symptoms on 26Jan. However, had a significantly swollen left underarm, same arm that she received the vaccine. Tender to touch. If the swelling doesn't go down in 1-2 days the patient will visit an urgent care. The patient underwent lab tests and procedures which included body temperature: 102 on 25Jan2021. Therapeutic measures were taken as a result of headache (headache), fever chills (pyrexia), backache (back pain). The patient did not receive treatment for the events vaccination site swelling, and vaccination site pain.  The outcome of the events headache, fever chills was recovered on 26Jan2021, while unknown for the events vaccination site swelling, and vaccination site pain.
Age: 28.0
Sex: M
Vaccine: COVID19
Symptoms: Condition aggravated, Tuberculin test, Tuberculin test positive, X-ray
Clinical narrative: Positive PPD skin test/Skin test flaring and still growing 5 days after administered; Positive PPD skin test/Skin test flaring and still growing 5 days after administered; This is a spontaneous report from a non-contactable nurse. A 28-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date not provided), intramuscular (left arm) first dose on 21Jan2021 12:00 at single dose for Covid-19 immunization.  The patient's medical history includes PPD skin test positive from 21Jan2021 3 hours prior Pfizer covid 19 vaccine injection. The patient's concomitant medications were not reported.  On 21Jan2021, PPD skin test done 3 hours prior Pfizer covid 19 vaccine injection on same left arm, Positive PPD skin test with clear x-ray with no history of positive PPD skin test. The patient had a separate negative PPD skin test in 2018 with negative results. On 23Jan2021 12:00, the patient skin test flaring and still growing 5 days after administered. Again the patient got the skin test the same day as the vaccine and have no history of a positive PPD skin test. The patient did not received treatment for the event. The outcome of the event was recovering.  No follow-up attempts are Possible. Information on Lot/batch number cannot be obtained. No further information is expected
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Myalgia, Nausea, Pyrexia
Clinical narrative: fever; tiredness; muscle aches; chills; nausea; This is a spontaneous report from a contactable consumer. A 54-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3302), via an unspecified route of administration on 25Jan2021 at 10:10 at a single dose on left arm for COVID-19 immunisation. The patient's medical history was not reported. There were no concomitant medications. This morning (26Jan2021), when the patient woke up, she had a fever. She was wondering if she would be contagious to her family. Confirmed she is not positive for COVID. She was just wondering if she would be contagious since she had a fever. She has experienced tiredness, muscle aches, fever, chills, and nausea this morning when she woke up. She is a little better at this point. She works at a doctor's office but is not a healthcare provider. The patient received the first dose of BNT162B2, lot number: EJ1686 on an unspecified date. The outcome of the events was recovering.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Abnormal dreams, Influenza like illness, Vaccination site pain
Clinical narrative: Pronounced soreness near injection site; Mild flu-like symptoms; vivid dream; This is a spontaneous report from a contactable consumer (patient).  A 76-year-old male patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL9261), via an unspecified route of administration in left arm on 22Jan2021 21:30 at a single dose for COVID-19 immunization. Medical history included none. Concomitant medication included levothyroxine sodium (THYROXINE), vitamin D, tamsulosin. The patient experienced pronounced soreness near injection site, mild flu-like symptoms, and vivid dream on 23Jan2021 01:00. Pronounced soreness near injection site. Mild flu-like symptoms strong for two hours and then diminishing with time. Very, vivid dream, detail rich, color, flashing light. No treatment received for the events. The outcome of the events was recovered on an unspecified date. The events were assessed as non-serious. Facility where the most recent COVID-19 vaccine was administered was Hospital. No other vaccines received within 4 weeks prior to the COVID vaccine. Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been been tested for COVID-19.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Muscular weakness, Vaccination site hypoaesthesia
Clinical narrative: Numbness and weakness in arm at injection site and below; Numbness and weakness in arm at injection site and below; Numbness and weakness in arm at injection site and below; This is a spontaneous report received from a contactable consumer (patient). A 24-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: el 3249, expiry date: unknown), via an unspecified route of administration in the arm, on 26Jan2021 10:45, at single dose, for COVID-19 immunization, at the hospital. Medical history included anxiety and depression. The patient was not pregnant at the time of vaccination. The patient was not diagnosed with COVID-19 prior to vaccination and was not tested for COVID-19 post vaccination. Concomitant medication included vilazodone hydrochloride (VIIBRYD), lamotrigine, acetylcysteine (NAC), betaine, citric acid monohydrate, cobamamide, cocarboxylase, flavine adenine dinucleotide, folic acid, folinic acid, iron amino acid chelate, magnesium ascorbate, magnesium levomefolate, nadh, nutrients nos, phosphatidyl serine, pyridoxal phosphate, sodium citrate, zinc ascorbate (ENLYTE), and probiotics. The patient previously took cefaclor (CECLOR) and experienced allergy. The patient did not receive any other vaccines within 4 weeks prior to BNT162B2 vaccine. The patient experienced numbness and weakness in arm at injection site and below on 26Jan2021 10:45. No treatment for the events was given. The patient was recovering from the events.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Dysgeusia, Fatigue, Headache
Clinical narrative: Fever/Undocumented fever; Chills; Numbness left body; Metallic taste; Headache; Body aches; Diarrhea; Fatigue; This is a spontaneous report from a contactable consumer (patient herself). A 30-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; lot number and expiration date were not reported), via an unspecified route of administration on 05Jan2021 16:45 at single dose on the left arm for COVID-19 immunization. The patient's medical history was not reported. The patient was not pregnant at the time of vaccination. The patient was taking an unspecified concomitant medication. The patient previously took first dose of BNT162B on 26Jan2021 at 16:15 for COVID-19 immunization. On 05Jan2021 at 18:00, the patient experienced every reaction that was possible to the vaccine including fever (also reported as undocumented fever), chills, numbness left body, metallic taste, headache, body aches, diarrhea, and fatigue. The events were reported as non-serious and no treatment was given to the patient. The patient was not diagnosed with COVID-19 prior to vaccination. The patient has been tested for COVID-19 with unknown results at the time of the report. The patient recovered from all of the events on an unspecified date.    Information on the lot/batch number has been requested.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Pain, Pyrexia, SARS-CoV-2 test
Clinical narrative: Fever/Undocumented fever; Chills; Numbness left body; Metallic taste; Headache; Body aches; Diarrhea; Fatigue; This is a spontaneous report from a contactable consumer (patient herself). A 30-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; lot number and expiration date were not reported), via an unspecified route of administration on 05Jan2021 16:45 at single dose on the left arm for COVID-19 immunization. The patient's medical history was not reported. The patient was not pregnant at the time of vaccination. The patient was taking an unspecified concomitant medication. The patient previously took first dose of BNT162B on 26Jan2021 at 16:15 for COVID-19 immunization. On 05Jan2021 at 18:00, the patient experienced every reaction that was possible to the vaccine including fever (also reported as undocumented fever), chills, numbness left body, metallic taste, headache, body aches, diarrhea, and fatigue. The events were reported as non-serious and no treatment was given to the patient. The patient was not diagnosed with COVID-19 prior to vaccination. The patient has been tested for COVID-19 with unknown results at the time of the report. The patient recovered from all of the events on an unspecified date.    Information on the lot/batch number has been requested.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Fear, Feeling hot, Hypoaesthesia, Paraesthesia
Clinical narrative: left face and ear were red and hot; left face and ear were red and hot; She got scared; side where the injection was given on her face felt like NOVOCAINE wearing out after the dentist/left side of the face cheeks to eye felt numb tingling, it felt different/like it was numb but not numb; left side of the face cheeks to eye felt numb tingling, it felt different; This is a spontaneous report from a contactable consumer (patient). A 68-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EZ9262), via an unspecified route of administration in the left arm on 25Jan2021 10:00 at a single dose for COVID-19 immunization. The patient's medical history included high cholesterol diagnosed a few years ago. Concomitant medication included atorvastatin for high cholesterol. The patient took the vaccine yesterday (25Jan2021) and the side where the injection was given on her face felt like procaine hydrochloride (NOVOCAINE) wearing out after the dentist and she doesn't see this listed on the sheet given. The left side of the face cheeks to eye felt numb tingling, it felt different. She wants to know if it's normal. She got the shot at 25Jan2021 10:00 and by 25Jan2021 17:00, her left face and ear were red and hot. Then, she felt her face. It felt like procaine hydrochloride wearing out after the dentist, like it was numb but not numb. She got scared and got up and looked at herself to see how it looked and there was no change. She scratched both sides of her face and they felt the same. It continued all night. This morning (26Jan2021), she thought it went away but she felt it all over again, not as much. She is not burning up, not like yesterday. She did not take her temperature; she should have to see if she had a low grade fever. Outcome of the event "she was scared" was unknown while of the remaining events was recovering.
Sex: F
Vaccine: COVID19
Symptoms: Back pain
Clinical narrative: I need to take Norco for a bad back/All I need you to tell me is if I can take Norco for my back pain,  and coded to back pain; This is a spontaneous report from a contactable consumer. A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, batch/lot and expiration date unknown), via an unspecified route of administration on 24Jan2021 at a single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient need to take Norco for a bad back,and coded to back pain. She have had a very bad back. She had the Pfizer vaccine this past Sunday. And need to if she could take Norco for her back pain. The outcome of the event was unknown.  Information on the Lot/Batch Number has been requested.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain lower, Influenza, Tinnitus
Clinical narrative: Lower abdominal pain; ringing in ears; aching joints, frontal headache, very tired/Felt like the worst flu ever; This is a spontaneous report from a contactable healthcare professional (patient). This 63-year-old male patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EL1283 and expiry date unknown), via an unspecified route of administration on 13Jan2021 10:30 at a single dose on the right arm for COVID-19 immunization. Medical history included asthma and allergies: sulfa drugs. The patient's concomitant medications were not reported. The patient was not diagnosed with COVID-19 prior to vaccination. Patient has not been tested for COVID-19 since the vaccination. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did fine until 23Jan2021 09:00 through 25Jan2021 as the patient experienced lower abdominal pain, aching joints, frontal headache, ringing in ears, and very tired. The patient stated that it felt like the worst flu ever. He also stated that his concern was will it be worse on the second injection. He may not take it. Events resulted in doctor or other healthcare professional office/clinic visit. No treatment was received. Outcome of the events was recovering.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Haemoptysis, SARS-CoV-2 test
Clinical narrative: hemoptysis; short breath; This is a spontaneous report from a contactable consumer (patient). A 71-year-old female patient (not pregnant) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EL9262), via an unspecified route of administration (left arm), on 21Jan2021 18:00, at single dose, for covid-19 immunization. Medical history included osteoporosis; there were no known allergies. There were no concomitant medications. The patient had no Covid prior vaccination. The vaccine was given at the hospital. The patient stated that on the next day after having the Pfizer-BioNTech Covid-19 vaccine, on 22Jan2021 15:00 the patient had short breath. On the 2nd day, 23Jan2021, the patient had hemoptysis. The patient does not know whether hemoptysis has something to do with the vaccine injection. The patient never had short breath nor hemoptysis in her life. These adverse events resulted in emergency room/department or urgent care visit. No treatment was received for the adverse events reported. At the time of the report, the patient had not recovered from the adverse events. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was Covid-tested post vaccination via nasal swab PCR on 25Jan2021 with results of negative.